Hainan Honz Pharmaceutical Co (300086) — Net Asset Quality Index
Hainan Honz Pharmaceutical Co (300086) has a Net Asset Quality Index of 51.9% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥1.71 Billion minus total liabilities of CN¥824.00 Million yields net assets of CN¥887.65 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read how much debt does Hainan Honz Pharmaceutical Co carry for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Hainan Honz Pharmaceutical Co Net Asset Quality Index Over Time (2007–2025)
This chart shows how Hainan Honz Pharmaceutical Co's Net Asset Quality Index has evolved across 19 annual periods from 2007 to 2025. As of June 2026, the index stands at 51.9%, representing net assets of CN¥887.65 Million against total assets of CN¥1.71 Billion CNY. For live market cap and overall valuation, see market value of Hainan Honz Pharmaceutical Co.
Annual Net Asset Quality Index for Hainan Honz Pharmaceutical Co (2007–2025)
The table below presents the year-by-year Net Asset Quality Index for Hainan Honz Pharmaceutical Co from 2007 to 2025, covering 19 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check Hainan Honz Pharmaceutical Co (300086) strategic asset index to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 51.4% | CN¥921.22 Million | CN¥1.79 Billion | CN¥869.79 Million | ▼ -7.5 pp |
| 2024 | 59.0% | CN¥1.17 Billion | CN¥1.98 Billion | CN¥810.53 Million | ▼ -4.7 pp |
| 2023 | 63.6% | CN¥1.38 Billion | CN¥2.17 Billion | CN¥787.60 Million | ▲ +4.4 pp |
| 2022 | 59.2% | CN¥1.36 Billion | CN¥2.29 Billion | CN¥932.96 Million | ▼ -4.0 pp |
| 2021 | 63.2% | CN¥1.55 Billion | CN¥2.46 Billion | CN¥905.14 Million | ▲ +1.9 pp |
| 2020 | 61.3% | CN¥1.60 Billion | CN¥2.61 Billion | CN¥1.01 Billion | ▼ -11.7 pp |
| 2019 | 73.0% | CN¥1.60 Billion | CN¥2.19 Billion | CN¥592.59 Million | ▼ -2.8 pp |
| 2018 | 75.8% | CN¥1.65 Billion | CN¥2.18 Billion | CN¥526.90 Million | ▼ -10.1 pp |
| 2017 | 85.9% | CN¥1.92 Billion | CN¥2.24 Billion | CN¥315.31 Million | ▲ +0.4 pp |
| 2016 | 85.5% | CN¥1.87 Billion | CN¥2.19 Billion | CN¥316.83 Million | ▼ -2.6 pp |
| 2015 | 88.1% | CN¥1.84 Billion | CN¥2.09 Billion | CN¥248.25 Million | ▼ -5.5 pp |
| 2014 | 93.6% | CN¥1.80 Billion | CN¥1.93 Billion | CN¥122.49 Million | ▼ -1.4 pp |
| 2013 | 95.0% | CN¥1.81 Billion | CN¥1.90 Billion | CN¥94.36 Million | ▼ -0.1 pp |
| 2012 | 95.2% | CN¥1.87 Billion | CN¥1.97 Billion | CN¥95.02 Million | ▲ +0.8 pp |
| 2011 | 94.4% | CN¥1.85 Billion | CN¥1.96 Billion | CN¥110.77 Million | ▼ -1.6 pp |
| 2010 | 96.0% | CN¥1.83 Billion | CN¥1.90 Billion | CN¥76.01 Million | ▲ +14.2 pp |
| 2009 | 81.8% | CN¥240.49 Million | CN¥294.09 Million | CN¥53.60 Million | ▲ +8.9 pp |
| 2008 | 72.9% | CN¥150.41 Million | CN¥206.34 Million | CN¥55.93 Million | ▼ -9.0 pp |
| 2007 | 81.9% | CN¥115.89 Million | CN¥141.57 Million | CN¥25.68 Million | — |